Sign In
Buy NYT
$74.89
-0.94 (-1.24%)
At Close: Jul 31, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ChowChow To Contact Him Directly To Discuss Their Options If you purchased or acquire
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ChowChow To Contact Him Directly To Discuss Their Options If you purchased or acquire
Will New York Times (NYT) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Friday, 24'th Apr 2026
New York Times (NYT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Concorde To Contact Him Directly To Discuss Their Options If you purchased or acquire
New York Times executive editor accused the Trump administration of trying to “criminalize routine reporting,” as the publication reported that one of its journalists was investigated by the FBI.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ChowChow To Contact Him Directly To Discuss Their Options If you purchased or acquire
New York Times seen as digitally strong, but fully valued by BofA
03:17pm, Wednesday, 22'nd Apr 2026
While The New York Times Company (NYSE:NYT) warrants a premium for its subscription mix and cash flow profile, analysts see the risk-reward as balanced, citing potential AI-related traffic disruptions
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Concorde To Contact Him Directly To Discuss Their Options If you purchased or acquire
Kuehn Law Encourages Investors of Vistagen Therapeutics, Inc. to Contact Law Firm
10:13am, Monday, 20'th Apr 2026
New York, New York--(Newsfile Corp. - April 20, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Vistagen Therapeutics, Inc . (NAS
KBC Group NV Lowers Holdings in The New York Times Company $NYT
05:07am, Monday, 20'th Apr 2026
KBC Group NV lowered its position in The New York Times Company (NYSE: NYT) by 14.3% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchan
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ChowChow To Contact Him Directly To Discuss Their Options If you purchased or acquire
Warren Buffett Dumped 77% of Berkshire's Amazon Stake and Opened a New Position in This Digital Media Juggernaut
07:50am, Sunday, 19'th Apr 2026
In his last quarter as CEO, Warren Buffett approved the sale of most of Berkshire's Amazon stock. Berkshire opened a new position in a digital media behemoth with a product Buffett has loved for a lon
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Concorde To Contact Him Directly To Discuss Their Options If you purchased or acquire
CHOW EQUITY ALERT: Faruqi & Faruqi, LLP Reminds ChowChow Cloud (CHOW) Investors of Securities Class Action Deadline on May 12, 2026
10:26am, Wednesday, 15'th Apr 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ChowChow To Contact Him Directly To Discuss Their Options If you purchased or acquire
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Concorde To Contact Him Directly To Discuss Their Options If you purchased or acquire
